PFM Health Sciences’s Tectonic Therapeutic TECX Stock Holding History

PFM Health Sciences’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.57M	Sell	45,631 -498	-1%	-$14.6K	0.13%	95
2026 Q1	$1.43M	Buy	46,129 +3,405	+8%	+$83.8K	0.13%	81
2025 Q4	$891K	Buy	+42,724	New	+$794K	0.09%	74
2019 Q4	–	Sell	-65,331	Closed	-$11.1M	–	83
2019 Q3	$11.1M	Buy	65,331 +44,545	+214%	+$10.1M	0.33%	59
2019 Q2	$4.06M	Buy	+20,786	New	+$4.48M	0.08%	79
2019 Q1	–	Sell	-20,118	Closed	-$4.02M	–	117
2018 Q4	$4.02M	Buy	20,118 +7,706	+62%	+$2.35M	0.11%	80
2018 Q3	$7.73M	Buy	+12,412	New	+$5.5M	0.11%	106

Other funds holding TECX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

PFM Health Sciences's TECX Position: Q2 2026 in Review

PFM Health Sciences reduced its Tectonic Therapeutic (TECX) stake by 1.1% in Q2 2026, selling an estimated $14.6K and leaving 45,631 shares worth $1.57M. The position accounts for 0.13% of the portfolio, ranked #95.

PFM Health Sciences first reported a position in TECX in Q3 2018 and has held it in 7 quarters since. The position peaked at $11.1M in Q3 2019. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

PFM Health Sciences held 45,631 shares of Tectonic Therapeutic worth $1.57M as of Q2 2026.
PFM Health Sciences sold 498 Tectonic Therapeutic shares in Q2 2026, an estimated $14.6K.
Tectonic Therapeutic made up 0.13% of PFM Health Sciences's portfolio in Q2 2026, its #95 holding.
PFM Health Sciences first reported a position in Tectonic Therapeutic in Q3 2018 and has held it in 7 quarters since.
PFM Health Sciences's Tectonic Therapeutic position peaked at $11.1M in Q3 2019.
123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.